These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 21910756

  • 1. In vitro synergy of pseudolaric acid B and fluconazole against clinical isolates of Candida albicans.
    Guo N, Ling G, Liang X, Jin J, Fan J, Qiu J, Song Y, Huang N, Wu X, Wang X, Deng X, Deng X, Yu L.
    Mycoses; 2011 Sep; 54(5):e400-6. PubMed ID: 21910756
    [Abstract] [Full Text] [Related]

  • 2. In vitro and in vivo interactions between fluconazole and allicin against clinical isolates of fluconazole-resistant Candida albicans determined by alternative methods.
    Guo N, Wu X, Yu L, Liu J, Meng R, Jin J, Lu H, Wang X, Yan S, Deng X.
    FEMS Immunol Med Microbiol; 2010 Mar; 58(2):193-201. PubMed ID: 19878317
    [Abstract] [Full Text] [Related]

  • 3. The synergy of honokiol and fluconazole against clinical isolates of azole-resistant Candida albicans.
    Jin J, Guo N, Zhang J, Ding Y, Tang X, Liang J, Li L, Deng X, Yu L.
    Lett Appl Microbiol; 2010 Sep; 51(3):351-7. PubMed ID: 20681969
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evaluation of anti-Candida potential of geranium oil constituents against clinical isolates of Candida albicans differentially sensitive to fluconazole: inhibition of growth, dimorphism and sensitization.
    Zore GB, Thakre AD, Rathod V, Karuppayil SM.
    Mycoses; 2011 Jul; 54(4):e99-109. PubMed ID: 20337938
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Synergistic and drug-resistant reversing effects of diorcinol D combined with fluconazole against Candida albicans.
    Li Y, Chang W, Zhang M, Li X, Jiao Y, Lou H.
    FEMS Yeast Res; 2015 Mar; 15(2):. PubMed ID: 25752309
    [Abstract] [Full Text] [Related]

  • 10. Proteomic analysis reveals a synergistic mechanism of fluconazole and berberine against fluconazole-resistant Candida albicans: endogenous ROS augmentation.
    Xu Y, Wang Y, Yan L, Liang RM, Dai BD, Tang RJ, Gao PH, Jiang YY.
    J Proteome Res; 2009 Nov; 8(11):5296-304. PubMed ID: 19754040
    [Abstract] [Full Text] [Related]

  • 11. The combination of minocycline and fluconazole causes synergistic growth inhibition against Candida albicans: an in vitro interaction of antifungal and antibacterial agents.
    Shi W, Chen Z, Chen X, Cao L, Liu P, Sun S.
    FEMS Yeast Res; 2010 Nov; 10(7):885-93. PubMed ID: 20707818
    [Abstract] [Full Text] [Related]

  • 12. In vitro interaction between azoles and cyclosporin A against clinical isolates of Candida albicans determined by the chequerboard method and time-kill curves.
    Li Y, Sun S, Guo Q, Ma L, Shi C, Su L, Li H.
    J Antimicrob Chemother; 2008 Mar; 61(3):577-85. PubMed ID: 18194958
    [Abstract] [Full Text] [Related]

  • 13. Caffeic acid phenethyl ester synergistically enhances the antifungal activity of fluconazole against resistant Candida albicans.
    Sun L, Liao K, Hang C.
    Phytomedicine; 2018 Feb 01; 40():55-58. PubMed ID: 29496175
    [Abstract] [Full Text] [Related]

  • 14. Synergistic Effect of Pseudolaric Acid B with Fluconazole Against Resistant Isolates and Biofilm of Candida tropicalis.
    Li Z, Yin H, Chen W, Jiang C, Hu J, Xue Y, Yao D, Peng Y, Hu X.
    Infect Drug Resist; 2020 Feb 01; 13():2733-2743. PubMed ID: 32801807
    [Abstract] [Full Text] [Related]

  • 15. In vitro synergy of eugenol and methyleugenol with fluconazole against clinical Candida isolates.
    Ahmad A, Khan A, Khan LA, Manzoor N.
    J Med Microbiol; 2010 Oct 01; 59(Pt 10):1178-1184. PubMed ID: 20634332
    [Abstract] [Full Text] [Related]

  • 16. Synergistic Antibiofilm Effects of Pseudolaric Acid A Combined with Fluconazole against Candida albicans via Inhibition of Adhesion and Yeast-To-Hypha Transition.
    Zhu B, Li Z, Yin H, Hu J, Xue Y, Zhang G, Zheng X, Chen W, Hu X.
    Microbiol Spectr; 2022 Apr 27; 10(2):e0147821. PubMed ID: 35297651
    [Abstract] [Full Text] [Related]

  • 17. Anti-candidal activity of essential oils alone and in combination with amphotericin B or fluconazole against multi-drug resistant isolates of Candida albicans.
    Khan MS, Malik A, Ahmad I.
    Med Mycol; 2012 Jan 27; 50(1):33-42. PubMed ID: 21756200
    [Abstract] [Full Text] [Related]

  • 18. Synergistic antifungal effect of lactoferrin with azole antifungals against Candida albicans and a proposal for a new treatment method for invasive candidiasis.
    Kobayashi T, Kakeya H, Miyazaki T, Izumikawa K, Yanagihara K, Ohno H, Yamamoto Y, Tashiro T, Kohno S.
    Jpn J Infect Dis; 2011 Jan 27; 64(4):292-6. PubMed ID: 21788703
    [Abstract] [Full Text] [Related]

  • 19. Antifungal activity of Rubus chingii extract combined with fluconazole against fluconazole-resistant Candida albicans.
    Han B, Chen J, Yu YQ, Cao YB, Jiang YY.
    Microbiol Immunol; 2016 Feb 27; 60(2):82-92. PubMed ID: 26891940
    [Abstract] [Full Text] [Related]

  • 20. Tetrandrine enhances the antifungal activity of fluconazole in a murine model of disseminated candidiasis.
    Shi J, Li S, Gao A, Zhu K, Zhang H.
    Phytomedicine; 2018 Jul 15; 46():21-31. PubMed ID: 30097119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.